There’s a new drink aiming to rapidly reduce blood alcohol levels. And it might be on the verge of a scientific breakthrough.
What’s happening:
- Safety Shot (NASDAQ: SHOT) has announced new data analysis from a recent clinical trial that shows significant validation for their proprietary drink being able to rapidly and significantly lower blood alcohol levels
By the numbers:
- The new clinical study found that within 30 minutes of an individual consuming Safety Shot’s proprietary drink that their blood alcohol levels were lowered 30-50% more than individuals who consumed a placebo
- Participants in the study also continued to see a noticeable drop in blood alcohol level over the following 60-90 minutes after initially consuming Safety Shot
Why it matters:
- Blood alcohol levels typically take many hours to lower naturally, which leaves individuals in a intoxicated state for prolonged periods of time without any alternative options
- There has never been a clinically approved supplement or drink that has been scientifically proven to be highly effective for being able to rapidly reduce blood alcohol levels in individuals
Going deeper:
- Safety Shot’s recent clinical trial was facilitated by The Centre For Applied Health Sciences in Ohio and had participants of different ages, genders and weight to attempt to accurately determine the efficacy of their drink on rapidly being able to lower blood alcohol level as well as produce positive physical outcomes such as reduced fatigue
- Safety Shot also recently announced a partnership with Capital Drugs to launch their drink into hundreds of their pharmacy locations across the United States of America
The intrigue:
- Safety Shot has launched a flurry of notable partnerships with celebrities, including collaborating with Kyle Forgead and John Shahidi who are the co-founders of popular seltzer Happy Dad and the Full Send media empire
